TrialTargeted oncology2023

Clinical Outcomes of First Subsequent Therapies After Abiraterone Acetate Plus Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer in the LATITUDE Study.

Yosuke Koroki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.